No Data
Dongguan Eontec (300328.SZ): The net income for the year 2024 is expected to decrease by 55.97%-70.65%.
On January 23, Gelonghui reported that Dongguan Eontec (300328.SZ) announced its 2024 performance forecast, stating that the Net income attributable to shareholders of the listed company would be between 1 million yuan and 1.5 million yuan, a decrease of 55.97% to 70.65% compared to the same period last year; the Net income after deducting non-recurring gains and losses is expected to incur a loss of 30 million yuan to 30.5 million yuan. During the reporting period, income from government subsidies confirmed was reduced, and losses from the disposal of fixed assets increased. It is estimated that the non-recurring gains and losses for the reporting period will be 31.5 million yuan, while the non-recurring gains and losses for the same period last year was 39.85 million yuan.
Yi\'an Technology: Yi\'an Technology 2024 Annual Performance Forecast
Dongguan Eontec (300328.SZ) plans to expand the investment scale of the liquid Metal project to 0.5 billion yuan.
Dongguan Eontec (300328.SZ) announced that the company's Board of Directors has reviewed and approved the "Expansion of the Liquid Metal Project..."
Dongguan Eontec (300328.SZ): The clinical trial summary report for biodegradable magnesium bone internal fixation screws has been obtained.
Glory Financial reported on January 7 that Dongguan Eontec (300328.SZ) announced that the company's biodegradable magnesium internal fixation screws successfully obtained the clinical trial summary report. The biodegradable magnesium internal fixation screws developed by the company are made of 99.99 wt.% high-purity magnesium, with a single element, no multi-element toxicity effects, and have the advantage of biological safety. They are used in minimally invasive surgery for hip preservation treatment, promoting bone growth and repair in the affected area. The biodegradable magnesium internal fixation screws have good biocompatibility and mechanical properties close to that of bone tissue, can promote bone formation, and gradually degrade while achieving in-body repair functions without leaving residues, avoiding secondary surgeries.
Dongguan Eontec's (SZSE:300328 Five-year Decrease in Earnings Delivers Investors With a 28% Loss
Dongguan Eontec (300328.SZ): Currently, liquid Metal products have not yet been involved in the field of Siasun Robot&Automation.
On December 31, Gelonghui reported that Dongguan Eontec (300328.SZ) stated on the investor interaction platform that the company's liquid Metal products have not yet been involved in the Siasun Robot&Automation sector.
Shareholders 33% Loss in Dongguan Eontec (SZSE:300328) Partly Attributable to the Company's Decline in Earnings Over Past Three Years
